SF2a-TT15 Conjugate Vaccine in Healthy Adult Volunteers

NCT02797236 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Shigellosis
Bacillary Dysentery

Interventions

BIOLOGICAL: SF2a-TT15 vaccine
BIOLOGICAL: SF2a-TT15 vaccine + adjuvant
BIOLOGICAL: Placebo
BIOLOGICAL: Placebo + adjuvant

Sponsor

Institut Pasteur